Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx and Biogen Idec in Structural Proteomics Collaboration; Syrrx Receives Milestone Payment

NEW YORK, May 27 (GenomeWeb News) - Syrrx has received a milestone payment from Biogen Idec in a structural proteomics collaboration the companies started at the end of last year, Syrrx said today.


Under the agreement, which the companies only announced now, San Diego-based Syrrx has been performing high-throughput crystallization of proteins on several targets provided by Biogen.


The companies said they also consider collaborating more broadly in the future.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.